Shanghai Rongtai Health Tech (603579) — Capital Reinvestment Ratio

Latest as of June 2025: 0.10x

Shanghai Rongtai Health Tech (603579) has a Capital Reinvestment Ratio of 0.10x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥124.41 Million) in capital expenditures (CN¥12.09 Million). See Shanghai Rongtai Health Tech free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.10x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥124.41 Million
CNY

Capital Expenditures

CN¥12.09 Million
CNY

Data as of

Jun 2025
Most recent filing

Shanghai Rongtai Health Tech Capital Reinvestment Ratio (2011–2025)

This chart tracks Shanghai Rongtai Health Tech's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Shanghai Rongtai Health Tech (2011–2025)

Year-by-year Capital Reinvestment Ratio for Shanghai Rongtai Health Tech from 2011 to 2025. For live market cap and broader valuation context, see 603579 market cap overview.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.64x CN¥174.77 Million CN¥111.86 Million ▼ -28.8%
2024 0.90x CN¥168.14 Million CN¥151.08 Million ▲ +245.2%
2023 0.26x CN¥344.29 Million CN¥89.61 Million ▼ -38.8%
2022 0.43x CN¥236.79 Million CN¥100.65 Million ▲ +1.5%
2021 0.42x CN¥337.92 Million CN¥141.46 Million ▼ -39.3%
2020 0.69x CN¥275.59 Million CN¥190.13 Million ▲ +90.9%
2019 0.36x CN¥446.47 Million CN¥161.38 Million ▼ -27.7%
2018 0.50x CN¥261.35 Million CN¥130.60 Million ▼ -11.4%
2017 0.56x CN¥281.17 Million CN¥158.57 Million ▲ +17.9%
2016 0.48x CN¥175.68 Million CN¥84.05 Million ▲ +135.1%
2015 0.20x CN¥214.60 Million CN¥43.67 Million ▼ -46.0%
2014 0.38x CN¥125.14 Million CN¥47.18 Million ▲ +7.4%
2013 0.35x CN¥76.76 Million CN¥26.95 Million ▼ -89.4%
2012 3.31x CN¥7.66 Million CN¥25.34 Million ▼ -38.5%
2011 5.38x CN¥3.73 Million CN¥20.07 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow